Idiopathic generalized epilepsy: genes and variants
Explore variant evidence for Idiopathic generalized epilepsy across 7 analyzed proteins (GABRA1, CASR, SLC2A1, KCNMA1, ABCB1 and 2 more). Linked ClinVar records include 38 pathogenic or likely pathogenic variants, 239 variants of uncertain significance and 62 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Idiopathic generalized epilepsy
GABRA1: Gamma-aminobutyric acid receptor subunit alpha-1
The gene product supplies the alpha-1 subunit of a pentameric GABA-A receptor, a ligand-gated chloride channel in the brain. GABA binding allows chloride influx that dampens neuronal activity, making this receptor important for inhibition and seizure biology.
24 ClinVar pathogenic / likely pathogenic and 168 uncertain variants in GABRA1 have source records linked to Idiopathic generalized epilepsy. Association strength is not clinical gene validity.
CASR: Extracellular calcium-sensing receptor
It senses extracellular calcium in the parathyroid gland and kidney and adjusts parathyroid-hormone secretion and renal calcium handling accordingly. Loss-of-function variants cause familial hypocalciuric hypercalcemia or neonatal severe hyperparathyroidism, whereas activating variants cause autosomal dominant hypocalcemia.
8 ClinVar pathogenic / likely pathogenic and 39 uncertain variants in CASR have source records linked to Idiopathic generalized epilepsy. Association strength is not clinical gene validity.
SLC2A1: Solute carrier family 2, facilitated glucose transporter member 1
It provides basal glucose uptake in many tissues and is the principal route for glucose entry across the blood-brain barrier. Haploinsufficiency causes GLUT1 deficiency syndrome with epilepsy, developmental impairment, and movement disorders from inadequate brain glucose delivery.
4 ClinVar pathogenic / likely pathogenic and 41 uncertain variants in SLC2A1 have source records linked to Idiopathic generalized epilepsy. Association strength is not clinical gene validity.
KCNMA1: Calcium-activated potassium channel subunit alpha-1
Its large-conductance potassium current couples membrane voltage and intracellular calcium to rapid repolarization in neurons, smooth muscle, and other excitable cells. Gain- and loss-of-function variants can cause paroxysmal dyskinesia, epilepsy, developmental impairment, and movement disorders.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in KCNMA1 have source records linked to Idiopathic generalized epilepsy. Association strength is not clinical gene validity.
ABCB1: ATP-dependent translocase ABCB1
It uses ATP to export a broad range of drugs and xenobiotics across intestinal, hepatic, renal, blood-brain-barrier, and other membranes. Its activity strongly influences drug absorption and tissue exposure and can contribute to multidrug resistance in cancer.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ABCB1 have source records linked to Idiopathic generalized epilepsy. Association strength is not clinical gene validity.
ZFHX3: Zinc finger homeobox protein 3
A large transcription factor with zinc-finger and homeobox DNA-binding domains. It regulates gene expression during neuronal and muscle differentiation and has been associated with atrial fibrillation.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ZFHX3 have source records linked to Idiopathic generalized epilepsy. Association strength is not clinical gene validity.
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Its hyperpolarization-activated current contributes substantially to spontaneous diastolic depolarization in sinoatrial-node pacemaker cells. Pathogenic variants can cause sinus bradycardia, conduction abnormalities, and in some families left-ventricular noncompaction.
0 ClinVar pathogenic / likely pathogenic and 48 uncertain variants in HCN4 have source records linked to Idiopathic generalized epilepsy. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Idiopathic generalized epilepsy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CASR E127K | 127 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| CASR E127A | 127 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| GABRA1 R214C | 214 | Extracellular | Pathogenic / likely pathogenic (★★) |
| CASR R220W | 220 | Ligand-binding 2 (LB2) | Pathogenic / likely pathogenic (★★) |
| GABRA1 R214H | 214 | Extracellular | Pathogenic / likely pathogenic (★★) |
| CASR L125P | 125 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| GABRA1 T289A | 289 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R223P | 223 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CASR V689M | 689 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| GABRA1 R147Q | 147 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R223W | 223 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SLC2A1 R458W | 458 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CASR R66C | 66 | Ligand-binding 1 (LB1) | Pathogenic / likely pathogenic (★★) |
| GABRA1 T295I | 295 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CASR R227Q | 227 | Ligand-binding 2 (LB2) | Pathogenic / likely pathogenic (★★) |
| GABRA1 P124L | 124 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 T292I | 292 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GABRA1 E277G | 277 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| GABRA1 S213T | 213 | Extracellular | Pathogenic / likely pathogenic (★) |
| CASR E191K | 191 | Ligand-binding 2 (LB2) | Pathogenic / likely pathogenic (★) |
| GABRA1 F42L | 42 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 I45T | 45 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 F92S | 92 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 Y187D | 187 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 A188D | 188 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 G251S | 251 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 Y252C | 252 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 M263T | 263 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GABRA1 L267F | 267 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GABRA1 N275K | 275 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| GABRA1 P280Q | 280 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GABRA1 T288I | 288 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GABRA1 F325L | 325 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A1 M420I | 420 | Transmembrane | Pathogenic / likely pathogenic (★) |
| GABRA1 Q28H | 28 | Extracellular | Pathogenic / likely pathogenic (★) |
| GABRA1 R2K | 2 | Pathogenic / likely pathogenic (★) | |
| ABCB1 S893Y | 893 | ABC transmembrane type-1 2 | Pathogenic / likely pathogenic |
| ZFHX3 P3618Q | 3618 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Idiopathic generalized epilepsy
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GABRA1 R214S | 214 | Extracellular | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R214H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.88 |
| GABRA1 N275S | 275 | Cytoplasmic | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; N275K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.66 |
| GABRA1 Y187C | 187 | Extracellular | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; Y187D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96 |
| GABRA1 Y187F | 187 | Extracellular | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; Y187D at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.729 |
| GABRA1 E277D | 277 | Cytoplasmic | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; E277G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97 |
Which prediction tools work for Idiopathic generalized epilepsy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 91 out of 100
- CATVariant: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 87 out of 100
- MetaLR: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- VARITY: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 84 out of 100
- SpliceAI: 77 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 74 out of 100
- SIFT: 72 out of 100
- EVE: 70 out of 100
- phastCons: 65 out of 100
- Pangolin: 42 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Developmental and epileptic encephalopathy also has ClinVar records linked to GABRA1 variants; they fall partly in the same places as the Idiopathic generalized epilepsy variants (15 pathogenic / likely pathogenic).
- Familial hypocalciuric hypercalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Idiopathic generalized epilepsy variants (81 pathogenic / likely pathogenic).
- Autosomal dominant hypocalcemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Idiopathic generalized epilepsy variants (69 pathogenic / likely pathogenic).
- Nephrolithiasis/nephrocalcinosis also has ClinVar records linked to CASR variants; they fall mostly in different places as the Idiopathic generalized epilepsy variants (14 pathogenic / likely pathogenic).
- Neonatal severe primary hyperparathyroidism also has ClinVar records linked to CASR variants; they fall partly in the same places as the Idiopathic generalized epilepsy variants (11 pathogenic / likely pathogenic).
- Familial hyperparathyroidism or Hypocalciuric hypercalcaemia also has ClinVar records linked to CASR variants; they fall mostly in different places as the Idiopathic generalized epilepsy variants (5 pathogenic / likely pathogenic).
- GLUT1 deficiency syndrome also has ClinVar records linked to SLC2A1 variants; they fall mostly in different places as the Idiopathic generalized epilepsy variants (53 pathogenic / likely pathogenic).
- Encephalopathy due to GLUT1 deficiency also has ClinVar records linked to SLC2A1 variants; they fall mostly in different places as the Idiopathic generalized epilepsy variants (32 pathogenic / likely pathogenic).
- Paroxysmal exertion-induced dyskinesia also has ClinVar records linked to SLC2A1 variants; they fall mostly in different places as the Idiopathic generalized epilepsy variants (18 pathogenic / likely pathogenic).
Diseases related to Idiopathic generalized epilepsy
- Cardiac arrhythmia, also linked to HCN4 and ZFHX3
- Developmental and epileptic encephalopathy, also linked to GABRA1
- Hypertrophic cardiomyopathy, also linked to CASR
- Familial hypocalciuric hypercalcemia, also linked to CASR
- EPILEPSY, CHILDHOOD ABSENCE, also linked to GABRA1
- Autosomal dominant hypocalcemia, also linked to CASR
- GLUT1 deficiency syndrome, also linked to SLC2A1
- Type 2 diabetes mellitus, also linked to ZFHX3
- Brugada syndrome, also linked to HCN4
- Encephalopathy due to GLUT1 deficiency, also linked to SLC2A1
- Paroxysmal exertion-induced dyskinesia, also linked to SLC2A1
- Epilepsy, also linked to GABRA1
Frequently asked questions
Which genes have records linked to Idiopathic generalized epilepsy?
This view contains 7 analyzed proteins: GABRA1, CASR, SLC2A1, KCNMA1, ABCB1 and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 38 pathogenic or likely pathogenic variants, 239 variants of uncertain significance and 62 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 5 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 357 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center